Phosphoprotein target for insulin and its antagonists

Research output: Patent

Abstract

The invention provides methods for diagnosing and treating individuals with insulin resistance.

@misc{8f5eaaddfd554717b1863c3f31e68e01,

title = "Phosphoprotein target for insulin and its antagonists",

abstract = "The invention provides methods for diagnosing and treating individuals with insulin resistance.",

author = "Garth Cooper and Limited, \{Protemix Corporation\} and \{Garth J. S.\}, Xu and Wang Aimin and [Unknown] Yu",

note = "Issuing organisation: USPLocation issued: USA; 6,884,575",

year = "2005",

month = apr,

day = "26",

language = "English",

type = "Patent",

}

TY - PAT

T1 - Phosphoprotein target for insulin and its antagonists

A2 - Cooper, Garth

A2 - Limited, Protemix Corporation

A2 - Garth J. S., Xu

A2 - Aimin, Wang

A2 - Yu, [Unknown]

N1 - Issuing organisation: USPLocation issued: USA

PY - 2005/4/26

Y1 - 2005/4/26

N2 - The invention provides methods for diagnosing and treating individuals with insulin resistance.

AB - The invention provides methods for diagnosing and treating individuals with insulin resistance.

M3 - Patent

M1 - 6,884,575

ER -